SABSW

SAB BIOTHERAPEUTICS INC

• Dow Jones·5d ago

  SAB Biotherapeutics Initiated at Buy by Citigroup

• Dow Jones·5d ago

  SAB Biotherapeutics Price Target Announced at $11.00/Share by Citigroup

• Benzinga·5d ago

  Citigroup Initiates Coverage On SAB Biotherapeutics with Buy Rating, Announces Price Target of $11

• TipRanks·6d ago

  SAB Biotherapeutics initiated with a Buy at Citi

• Benzinga·05/20 12:53

  This QuickLogic Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

• Dow Jones·05/20 12:44

  SAB Biotherapeutics Price Target Announced at $11.00/Share by Jefferies

• Benzinga·05/20 12:34

  Jefferies Initiates Coverage On SAB Biotherapeutics with Buy Rating, Announces Price Target of $11

• TipRanks·05/20 09:10

  Analysts’ Top Healthcare Picks: Hims & Hers Health (HIMS), SAB Biotherapeutics (SABS)

• TipRanks·05/20 09:05

  SAB Biotherapeutics initiated with a Buy at Jefferies

• TipRanks·05/20 09:01

  Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and SAB Biotherapeutics (SABS)

• TipRanks·05/14 08:40

  Analysts Conflicted on These Healthcare Names: Qiagen (QGEN), SAB Biotherapeutics (SABS) and Moderna (MRNA)

• TipRanks·05/13 03:55

  Chardan Capital Keeps Their Buy Rating on SAB Biotherapeutics (SABS)

• TipRanks·05/12 18:00

  SAB Biotherapeutics price target raised to $10 from $7 at H.C. Wainwright

• Dow Jones·05/12 17:04

  SAB Biotherapeutics Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·05/12 17:04

  SAB Biotherapeutics Price Target Raised to $10.00/Share From $7.00 by HC Wainwright & Co.